Suneel Gupta

Insider Reports History

Entity
Individual
Location
7707 Gateway Blvd., Suite 140, Newark, CA
Signature
/s/ Matthew Gosling, Attorney-in-Fact for Suneel Gupta
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Suneel Gupta:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Protagonist Therapeutics, Inc Chief Development Officer Common Stock 183K $5.41M $29.53 Feb 26, 2024 Direct
Protagonist Therapeutics, Inc Chief Development Officer Stock Option (right to buy) 45K Jan 9, 2024 Direct

Insider Reports Filed by Suneel Gupta

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PTGX Protagonist Therapeutics, Inc Feb 26, 2024 1 -$126K 4 Feb 28, 2024 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Jan 9, 2024 3 -$88.1K 4 Jan 11, 2024 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Jan 2, 2024 2 $0 4 Jan 4, 2024 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Oct 19, 2023 2 $148K 4 Oct 23, 2023 Chief Development Officer
PTGX Protagonist Therapeutics, Inc May 31, 2023 2 -$108K 4 Jun 2, 2023 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Jan 16, 2023 2 $0 4 Jan 18, 2023 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Apr 26, 2022 2 $295K 4 Apr 26, 2022 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Feb 28, 2022 1 -$15.8K 4 Mar 2, 2022 Chief Development Officer
PTGX Protagonist Therapeutics, Inc Feb 15, 2022 2 $0 4 Feb 17, 2022 Chief Development Officer